PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE.
作者信息
HELLMANN K, DUKE D I, TUCKER D F
出版信息
Br Med J. 1965 Sep 18;2(5463):687-9. doi: 10.1136/bmj.2.5463.687.
Abstract
摘要
相似文献
1
PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE.
Br Med J. 1965 Sep 18;2(5463):687-9. doi: 10.1136/bmj.2.5463.687.
2
SUPPRESSION OF THE HOMOGRAFT RESPONSE BY PURINETHIOL NUCLEOSIDES.
Proc Soc Exp Biol Med. 1965 May;119:248-52. doi: 10.3181/00379727-119-30149.
3
EFFECT OF URACIL MUSTARD ON THE HOMOGRAFT RESPONSE IN RABBITS.
Transplantation. 1965 Jul;3:580-1. doi: 10.1097/00007890-196507000-00017.
4
DIFFERENTIAL SKIN AND RENAL HOMOGRAFT SURVIVAL IN DOGS ON IMMUNOSUPPRESSIVE THERAPY.
Surg Forum. 1964;15:166-8.
5
HOST-TUMOR ANTAGONISM. 34. THE USE OF PROGESTATIONAL AGENTS TO RETARD HOMOGRAFT REJECTION IN RABBITS; A PILOT STUDY.
J Am Geriatr Soc. 1965 Aug;13:765-71. doi: 10.1111/j.1532-5415.1965.tb00634.x.
6
MODIFICATION OF THE HOMOGRAFT REACTION IN CORNEAL TRANSPLANTATION: A PRELIMINARY REPORT.
Ann N Y Acad Sci. 1964 Nov 30;120:802-6. doi: 10.1111/j.1749-6632.1964.tb34772.x.
7
Effect of thalidomide on the immunological response in local lymph nodes after a skin homograft.
Lancet. 1966 May 21;1(7447):1134-6. doi: 10.1016/s0140-6736(66)91143-3.
8
THE EFFECT OF HOMOGRAFT ANTIGEN STRENGTH ON THE EMERGENCE OF 6-MERCAPTOPURINE-RESISTANT, IMMUNE COMPETENT CELLS.
J Surg Res. 1965 Feb;5:79-89. doi: 10.1016/s0022-4804(65)80070-1.
9
INDUCTION OF TOLERANCE TO MOUSE TAIL SKIN HOMOGRAFTS BY COMBINING PAIRED IMMUNOSUPPRESSIVE AGENTS AND CELLULAR ANTIGENS.
Transplantation. 1965 Mar;3:131-9. doi: 10.1097/00007890-196503000-00001.
10
PROLONGATION OF HOMOGRAFT SURVIVAL BY METHOTREXATE WITH PROTECTION AGAINST TOXICITY BY FOLINIC ACID.
Lancet. 1964 Dec 26;2(7374):1363-5. doi: 10.1016/s0140-6736(64)91157-2.
引用本文的文献
1
Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts.
BMC Immunol. 2020 Apr 16;21(1):19. doi: 10.1186/s12865-020-00352-1.
2
Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model.
World J Surg. 2003 Oct;27(10):1119-23. doi: 10.1007/s00268-003-7009-5. Epub 2003 Sep 4.
3
Thalidomide: an antineoplastic agent.
Curr Oncol Rep. 2002 Jan;4(1):56-62. doi: 10.1007/s11912-002-0048-5.
4
Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood.
Arch Toxicol. 1993;67(1):1-17. doi: 10.1007/BF02072029.
5
Teratogenesis and lymphocyte stimulation.
Br Med J. 1969 Jul 5;3(5661):52. doi: 10.1136/bmj.3.5661.52.
6
The effect of two soluble thalidomide derivatives on lymphocyte stimulation.
Clin Exp Immunol. 1970 Aug;7(2):241-7.
7
Tumour host relationships.
Br J Cancer. 1967 Mar;21(1):27-32. doi: 10.1038/bjc.1967.4.
8
Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug.
Proc Natl Acad Sci U S A. 1970 Aug;66(4):1089-95. doi: 10.1073/pnas.66.4.1089.
9
Prolonged survival of glutaraldehyde-treated skin homografts.
Proc Natl Acad Sci U S A. 1971 Jul;68(7):1590-3. doi: 10.1073/pnas.68.7.1590.
10
[Immunosuppression by cyclic imides in the rat].
Klin Wochenschr. 1967 Nov 15;45(22):1159-60. doi: 10.1007/BF01727401.
本文引用的文献
1
THALIDOMIDE AND INDUCED AMPHIBIAN METAMORPHOSIS.
Nature. 1964 Dec 5;204:939-40. doi: 10.1038/204939a0.
2
SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDE.
Transplantation. 1964 Jul;2:475-86. doi: 10.1097/00007890-196407000-00004.
3
Chemical suppression of the immune response.
Pharmacol Rev. 1963 Jun;15:365-405.
4
The use of antigenic tissue extracts to weaken the immunological reaction against skin homografts in mice.
Transplantation. 1963 Jan;1:21-38. doi: 10.1097/00007890-196301010-00004.
5
Alteration of the homograft response by antimetabolites.
Ann N Y Acad Sci. 1960 May 31;87:203-13. doi: 10.1111/j.1749-6632.1960.tb23193.x.
Zotero 插件